Fulgent Genetics Inc (Nasdaq:FLGT)
April 23rd, 2019
With markets going up Fulgent Genetics Inc closed Tuesday up 9.21%, a $0.62 increase to close on $7.35. Furthermore it hit a new 52 week high of $7.50. The stock continues to trade well at 143.38% of its 52 week low of $3.02. In addition to finishing higher, trading volumes were solid at 214.00% of normal which can indicate investors see opportunities.
Expectations from 2 analysts indicates that Fulgent Genetics Inc could decline somewhat (-23.48%), while Finbox has calculated (with very high uncertainty) a fair value price of $5.01.
The market sectors were mixed Tuesday with a majority of the sectors trending up. Healthcare saw the biggest increase of the day (1.59%), while Consumer Staples saw the biggest drop (-0.12%). Information Technology has seen the biggest year-to-date gain at 25.74%. The biggest loss this year has been the Healthcare sector falling -0.69%.
Healthcare saw the biggest turnaround from its 5-day performance of -4.33%, as it went up 1.59%. Consumer Staples saw a turn around from its 5-day performance of 0.92% trading down -0.12%.
- Healthcare went up with a 1.59% change.
- Consumer Discretionary went up with a 1.22% change.
- Information Technology went up with a 1.13% change.
- Real Estate went up with a 1.12% change.
- Industrials went up with a 0.89% change.
- Communication Services went up with a 0.85% change.
- Financials went up with a 0.58% change.
- Materials went up with a 0.44% change.
- Utilities went up with a 0.37% change.
- Energy went up with a 0.04% change.
- Consumer Staples went down with a -0.12% change.
Fulgent Genetics Inc Info
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It markets its tests through internal sales force, as well as through independent sales representatives in the United States, Canada, the People’s Republic of China, and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
All amounts in USD unless otherwise indicated
Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.